Eric Burak - 01 Feb 2022 Form 4 Insider Report for Fusion Pharmaceuticals Inc.

Role
Chief? Scientific Officer
Signature
/s/Maria Stahl as Attorney-in-Fact for Eric Burak
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 18:36:11 UTC
Next filing
09 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +168,200 $0.000000 168,200 01 Feb 2022 Common Stock 168,200 $7.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments beginning on March 1, 2022.